| Title |
Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
|
|---|---|
| Published in |
BMC Neurology, September 2019
|
| DOI | 10.1186/s12883-019-1443-y |
| Pubmed ID | |
| Authors |
Thomas Meyer, Andreas Funke, Christoph Münch, Dagmar Kettemann, André Maier, Bertram Walter, Annett Thomas, Susanne Spittel |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 18% |
| Portugal | 2 | 5% |
| Canada | 2 | 5% |
| United Kingdom | 2 | 5% |
| South Africa | 1 | 3% |
| Comoros | 1 | 3% |
| Germany | 1 | 3% |
| Turkey | 1 | 3% |
| Japan | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 20 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 31 | 82% |
| Practitioners (doctors, other healthcare professionals) | 6 | 16% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 132 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 19 | 14% |
| Student > Master | 15 | 11% |
| Student > Ph. D. Student | 14 | 11% |
| Researcher | 13 | 10% |
| Student > Doctoral Student | 8 | 6% |
| Other | 24 | 18% |
| Unknown | 39 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 19% |
| Neuroscience | 13 | 10% |
| Biochemistry, Genetics and Molecular Biology | 10 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Psychology | 6 | 5% |
| Other | 27 | 20% |
| Unknown | 43 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2023.
All research outputs
#629,201
of 25,634,695 outputs
Outputs from BMC Neurology
#33
of 2,716 outputs
Outputs of similar age
#13,156
of 352,384 outputs
Outputs of similar age from BMC Neurology
#2
of 36 outputs
Altmetric has tracked 25,634,695 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,716 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,384 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.